Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial

May 30, 2025Addiction (Abingdon, England)

Effectiveness of prolonged exposure, eye movement therapy, and imagery rescripting for PTSD in patients also using substances: A randomized trial

AI simplified

Psychedelic Science on OpenScience ↗PubMed ↗DOI ↗

Abstract

Among 209 patients with co-occurring substance use disorder (SUD) and post-traumatic stress disorder (PTSD), the addition of trauma-focused treatments significantly reduced PTSD severity compared to SUD treatment alone.

SUD + Eye Movement Desensitization and Reprocessing (EMDR) resulted in a mean CAPS-5 score difference of -7.97, indicating significant improvement.
SUD + Imagery Rescripting (ImRs) showed the greatest mean score difference of -10.03, suggesting a substantial reduction in PTSD severity.
SUD + Prolonged Exposure (PE) had a mean score difference of -5.41, which approached statistical significance.
No significant differences in substance use outcomes were observed across the treatment groups, indicating that PTSD treatments did not exacerbate SUD severity.

AI simplified

BACKGROUND AND AIMS: Post-traumatic stress disorder (PTSD) and substance use disorder (SUD) are highly co-occurring and evidence for the optimal ways of treating PTSD in SUD patients is mixed. Our aim was to compare three different PTSD treatments, each added simultaneously to SUD treatment, with SUD treatment alone in patients with co-occurring SUD-PTSD. These PTSD treatments were: Prolonged Exposure (PE), Eye Movement Desensitization and Reprocessing (EMDR) and Imagery Rescripting (ImRs).

DESIGN: A single-blind 4-arm randomized controlled trial with follow-up at 3 months.

SETTING: Two addiction treatment centers in the Netherlands, providing intra- and extramural care.

PARTICIPANTS: 209 patients with SUD and co-morbid PTSD were included [mean age 37.5 (standard deviation, SD = 11.99), female sex = 46.4%, mean Clinically Administered PTSD Scale (CAPS) score = 37.35 (SD = 9.28)].

INTERVENTIONS: Participants were randomized to either simultaneous SUD + PE (n = 53), SUD + EMDR (n = 50), SUD + ImRs (n = 55) or to SUD treatment only (n = 51), with the active PTSD treatments consisting of 12 sessions each within 3 months. Standard protocols were used.

MEASUREMENTS: The primary outcome was clinician-administered PTSD symptom severity as measured by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (CAPS-5) at 3 month follow-up. Secondary outcomes included loss of PTSD diagnosis, full remission of PSTD and SUD-severity, also recorded at 3 months.

FINDINGS: Compared with SUD only, the mean differences in CAPS-5 score were B = -5.41 [95% confidence interval (CI) = 10.88, 0.05, P = 0.052] for SUD + PE, B = -7.97 (95% CI = -13.57, -2.37, P = 0.006) for SUD + EMDR and B = -10.03 (95% CI = -15.29, -4.77, P < 0.001) for SUD + ImRs. When adjusted for baseline covariates, mean differences were B = -5.81 (95% CI = -11.48, -0.15, P = 0.044) for SUD + PE, B = -8.85 (95% CI = -14.60, -3.10, P = 0.003) for SUD + EMDR and B = -10.75 (95% CI = -15.94, -5.56, P = <0.001) for SUD + ImRs. No between-group differences in SUD outcomes were found.

CONCLUSIONS: Among people with co-occurring substance use disorder (SUD) and post-traumatic stress disorder (PTSD), trauma-focused PTSD treatment as add-on to SUD treatment appears to be effective in decreasing PTSD severity compared with manualized SUD only treatment and does not appear to increase SUD severity.

Full Text

Full text is available at the source.

View full text ↗

Effectiveness of treating post‐traumatic stress disorder in patients with co‐occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the psychedelic science brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the psychedelic science brief